Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 18.54%11.68B | -582.51%-1.85B | -13.89%30.13B | -25.14%8.9B | 20.26%9.85B | -81.69%383M | 41.28%34.98B | -27.78%12.81B | 405.27%11.89B | -13.09%8.19B |
| Net profit before non-cash adjustment | -15.88%7.08B | 2.55%9B | 11.20%32.69B | 2.16%9.24B | 8.37%8.42B | 9.92%8.77B | 5.57%29.4B | -29.17%4.6B | 14.43%9.05B | 26.67%7.77B |
| Total adjustment of non-cash items | -7.29%1.58B | 96.45%-28M | -21.00%5.95B | -48.34%761M | 163.72%1.7B | -385.87%-789M | 10.27%7.54B | 52.24%5.14B | 62.05%1.47B | -72.13%645M |
| -Depreciation and amortization | -1.98%1.58B | -2.73%1.57B | -0.89%6.5B | -0.31%1.63B | -1.53%1.61B | -1.53%1.61B | 13.97%6.55B | 7.53%1.64B | 12.62%1.63B | 13.43%1.64B |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | --0 | ---- | ---- | ---- | --639M | ---- | ---- | ---- |
| -Disposal profit | --0 | --0 | -621.43%-1.01B | --0 | ---544M | -232.86%-466M | ---140M | --0 | --0 | --0 |
| -Other non-cash items | -100.79%-5M | 17.51%-1.6B | -3.11%468M | -441.88%-867M | 163.48%631M | -58.43%-1.94B | -55.40%483M | 54.62%2.86B | 70.43%-160M | -214.38%-994M |
| Changes in working capital | 1,223.42%3.02B | -42.37%-10.82B | -336.39%-8.51B | -180.13%-1.1B | -19.56%-269M | -23.23%-7.6B | 80.32%-1.95B | -61.04%3.07B | 121.26%1.37B | -122.89%-225M |
| -Change in receivables | -684.17%-1.09B | -51.84%-15.83B | -7.79%-4.96B | -7,489.53%-6.36B | 96.69%-139M | -4.85%-10.43B | 62.45%-4.6B | -44.24%9.46B | 100.72%86M | 22.89%-4.2B |
| -Change in inventory | 168.78%1.83B | 13.24%-2.7B | -4,198.72%-3.35B | -10.89%-13.83B | 19.33%679M | -44.43%-3.11B | 97.63%-78M | 8.45%13.98B | 4.48%-12.47B | 114.40%569M |
| -Change in payables | 498.54%3.29B | 29.50%6.81B | -75.18%452M | 37.52%20B | -86.25%549M | 2.52%5.26B | -70.10%1.82B | 3.66%-21.84B | -25.09%14.54B | -64.91%3.99B |
| -Provision for loans, leases and other losses | 26.44%-999M | 32.60%907M | -172.68%-657M | -16.77%-919M | -133.33%-1.36B | -15.14%684M | 290.32%904M | 115.74%1.47B | 1.87%-787M | 41.27%-582M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 0 | 0 | -166.67%-8M | 0 | 0 | -2M | 40.00%-3M | 40.00%-3M | 0 | 0 |
| Interest received (cash flow from operating activities) | 16.39%142M | 1.68%182M | 14.92%516M | 5.41%117M | 18.45%122M | 16.23%179M | 16.62%449M | 5.19%81M | 12.12%111M | 33.77%103M |
| Tax refund paid | 0 | 3.12%-4.81B | -13.73%-9.56B | -8.79%-4.59B | 0 | -18.73%-4.96B | -0.19%-8.4B | 0 | 1.12%-4.22B | 0 |
| Other operating cash inflow (outflow) | 0 | 1,188.64%479M | -69.92%-401M | 0 | -17,750.00%-357M | -4,500.00%-44M | -47.50%-236M | -148.26%-236M | 101.56%1M | 99.06%-2M |
| Operating cash flow | 22.92%11.82B | -34.80%-6B | -22.83%20.68B | -43.13%4.42B | 15.97%9.62B | -129.99%-4.45B | 61.44%26.79B | -30.86%12.65B | 513.06%7.78B | -10.73%8.29B |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -529.73%-699M | 2.19%-312M | 76.65%-1.32B | -81.61%-474M | 52.36%-111M | 92.94%-319M | -2.09%-5.67B | -228.00%-656M | 76.72%-261M | 94.43%-233M |
| Net intangibles purchase and sale | -22.22%-66M | -38.89%-50M | -56.52%-216M | -36.36%-75M | -92.86%-54M | -38.46%-36M | 38.12%-138M | 36.96%-29M | -34.15%-55M | 40.43%-28M |
| Net business purchase and sale | ---- | ---- | 89.93%-14M | ---- | ---- | ---- | -25.23%-139M | ---139M | ---- | ---- |
| Net investment product transactions | -135.48%-314M | -106.76%-33M | 520.57%1.33B | 73.08%-35M | 7,475.00%885M | 109.44%488M | -315.79%-316M | -4,422.22%-407M | -348.28%-130M | -9.09%-12M |
| Net changes in other investments | -3,150.00%-65M | -966.67%-32M | -2,166.67%-204M | ---194M | ---2M | -50.00%-3M | 93.23%-9M | ---- | ---- | --0 |
| Investing cash flow | -259.33%-1.14B | -428.46%-427M | 93.17%-428M | -78.38%-792M | 363.00%718M | 103.02%130M | -2.87%-6.27B | -347.65%-1.24B | 68.19%-444M | 93.61%-273M |
| Financing cash flow | ||||||||||
| Net common stock issuance | ---- | ---- | ---5B | ---2.19B | ---1.5B | --0 | --0 | --0 | --0 | --0 |
| Increase or decrease of lease financing | -21.43%-34M | 10.00%-27M | -3.45%-120M | 9.68%-28M | 15.15%-28M | -11.11%-30M | 22.15%-116M | 34.21%-25M | 13.89%-31M | 10.81%-33M |
| Cash dividends paid | 66.67%-4M | -10.43%-3.39B | -14.80%-6.2B | -10.51%-3.12B | -140.00%-12M | -19.29%-3.07B | -7.50%-5.4B | -50.00%-3M | -9.71%-2.83B | -25.00%-5M |
| Net other fund-raising expenses | ---- | ---- | ---1M | ---- | ---- | ---- | ---- | ---- | --0 | --1M |
| Financing cash flow | 35.88%-990M | -10.24%-3.41B | -105.14%-11.32B | -87.04%-5.34B | -4,072.97%-1.54B | -19.12%-3.1B | -6.63%-5.52B | 30.77%-27M | -9.34%-2.86B | 9.76%-37M |
| Net cash flow | ||||||||||
| Beginning cash position | 12.13%60.08B | 14.63%69.92B | 32.62%60.99B | 38.20%62.37B | 44.24%53.58B | 32.62%60.99B | 13.09%45.99B | 77.12%49.61B | 33.13%45.13B | 28.44%37.15B |
| Current changes in cash | 10.19%9.69B | -32.66%-9.84B | -40.52%8.92B | -138.21%-1.71B | 10.12%8.79B | 16.17%-7.42B | 181.78%15B | -36.69%11.39B | 176.01%4.48B | 60.40%7.98B |
| Cash adjustments other than cash changes | --0 | 0.00%-1M | 0.00%-1M | ---- | 100.00%2M | 50.00%-1M | 0.00%-1M | --0 | --0 | --1M |
| End cash Position | 11.85%69.77B | 12.13%60.08B | 14.63%69.92B | 22.28%60.66B | 38.20%62.37B | 44.24%53.58B | 32.62%60.99B | 32.62%60.99B | 77.12%49.61B | 33.13%45.13B |
| Free cash flow | 16.97%11.06B | -32.38%-6.36B | -9.21%19.05B | -48.22%3.86B | 17.68%9.45B | 25.83%-4.8B | 93.94%20.99B | -33.71%11.97B | 345.06%7.46B | 58.80%8.03B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |